JP5083967B2 - ヒドロゲルを形成する、偽熱硬化性の中和されたキトサン組成物、および、この組成物を製造するためのプロセス - Google Patents
ヒドロゲルを形成する、偽熱硬化性の中和されたキトサン組成物、および、この組成物を製造するためのプロセス Download PDFInfo
- Publication number
- JP5083967B2 JP5083967B2 JP2007504258A JP2007504258A JP5083967B2 JP 5083967 B2 JP5083967 B2 JP 5083967B2 JP 2007504258 A JP2007504258 A JP 2007504258A JP 2007504258 A JP2007504258 A JP 2007504258A JP 5083967 B2 JP5083967 B2 JP 5083967B2
- Authority
- JP
- Japan
- Prior art keywords
- chitosan
- solution
- hydrogel
- deacetylation
- cooled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920001661 Chitosan Polymers 0.000 title claims description 247
- 239000000017 hydrogel Substances 0.000 title claims description 106
- 238000000034 method Methods 0.000 title claims description 50
- 239000000203 mixture Substances 0.000 title claims description 40
- 230000008569 process Effects 0.000 title claims description 35
- 229920001187 thermosetting polymer Polymers 0.000 title claims description 25
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 69
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 63
- 239000000243 solution Substances 0.000 claims description 59
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 57
- 238000003381 deacetylation reaction Methods 0.000 claims description 44
- 230000006196 deacetylation Effects 0.000 claims description 43
- 239000002245 particle Substances 0.000 claims description 18
- 239000003929 acidic solution Substances 0.000 claims description 13
- 150000002009 diols Chemical class 0.000 claims description 13
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 230000002378 acidificating effect Effects 0.000 claims description 8
- 230000001376 precipitating effect Effects 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 230000007928 solubilization Effects 0.000 claims description 7
- 238000005063 solubilization Methods 0.000 claims description 7
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 6
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 6
- 230000007935 neutral effect Effects 0.000 claims description 6
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 239000002609 medium Substances 0.000 claims description 5
- 230000003472 neutralizing effect Effects 0.000 claims description 5
- 230000003381 solubilizing effect Effects 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000001248 thermal gelation Methods 0.000 claims description 4
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 3
- 239000012736 aqueous medium Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 37
- DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 32
- 238000002360 preparation method Methods 0.000 description 27
- 238000003756 stirring Methods 0.000 description 22
- 229910019142 PO4 Inorganic materials 0.000 description 17
- 235000021317 phosphate Nutrition 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 14
- 239000010452 phosphate Substances 0.000 description 14
- 239000000499 gel Substances 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 11
- 238000006386 neutralization reaction Methods 0.000 description 10
- 238000001556 precipitation Methods 0.000 description 9
- 229920002101 Chitin Polymers 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 239000000178 monomer Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000001879 gelation Methods 0.000 description 6
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 238000012377 drug delivery Methods 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229950006780 n-acetylglucosamine Drugs 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- 238000001542 size-exclusion chromatography Methods 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 241000238557 Decapoda Species 0.000 description 2
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical group N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- FUSNOPLQVRUIIM-UHFFFAOYSA-N 4-amino-2-(4,4-dimethyl-2-oxoimidazolidin-1-yl)-n-[3-(trifluoromethyl)phenyl]pyrimidine-5-carboxamide Chemical compound O=C1NC(C)(C)CN1C(N=C1N)=NC=C1C(=O)NC1=CC=CC(C(F)(F)F)=C1 FUSNOPLQVRUIIM-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- 239000012493 hydrazine sulfate Substances 0.000 description 1
- 229910000377 hydrazine sulfate Inorganic materials 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- -1 sugars monophosphate Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2004/002988 WO2005097871A1 (en) | 2004-03-22 | 2004-03-22 | Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007529559A JP2007529559A (ja) | 2007-10-25 |
| JP2007529559A5 JP2007529559A5 (enExample) | 2011-01-13 |
| JP5083967B2 true JP5083967B2 (ja) | 2012-11-28 |
Family
ID=34957126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007504258A Expired - Fee Related JP5083967B2 (ja) | 2004-03-22 | 2004-03-22 | ヒドロゲルを形成する、偽熱硬化性の中和されたキトサン組成物、および、この組成物を製造するためのプロセス |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US8835514B2 (enExample) |
| EP (1) | EP1730216A1 (enExample) |
| JP (1) | JP5083967B2 (enExample) |
| CA (1) | CA2560432C (enExample) |
| WO (1) | WO2005097871A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005097871A1 (en) * | 2004-03-22 | 2005-10-20 | Universite De Geneve | Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same |
| CN1330386C (zh) * | 2005-12-07 | 2007-08-08 | 浙江大学 | 用于组织工程的可注射性壳聚糖水凝胶的制备方法 |
| CN100431624C (zh) * | 2005-12-07 | 2008-11-12 | 浙江大学 | 可注射聚乳酸微载体/壳聚糖水凝胶复合支架的制备方法 |
| PT1978925E (pt) * | 2005-12-23 | 2009-11-19 | Medidom Lab | Composição termoendurecível de quitosano neutralizado que forma um hidrogel, liofililizado, e a um processo para a produção do mesmo |
| US9034348B2 (en) | 2006-12-11 | 2015-05-19 | Chi2Gel Ltd. | Injectable chitosan mixtures forming hydrogels |
| JP2011511123A (ja) * | 2008-01-31 | 2011-04-07 | ザ プロクター アンド ギャンブル カンパニー | キトサンのアセチル化 |
| CA2727588A1 (en) * | 2008-06-11 | 2009-12-17 | Chi2Gel Ltd. | Injectable hydrogel forming chitosan mixtures |
| EP3569262A1 (en) * | 2013-03-14 | 2019-11-20 | Tricol Biomedical, Inc. | Biocompatible and bioabsorbable derivatized chitosan compositions |
| FR3016882A1 (fr) | 2014-01-30 | 2015-07-31 | Sofradim Production | Procede de preparation de chitosane a haut degre d’acetylation |
| CN114805859B (zh) * | 2022-06-16 | 2023-08-29 | 安阳师范学院 | 一种热定型壳聚糖水凝胶的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4659700A (en) * | 1984-03-02 | 1987-04-21 | Johnson & Johnson Products, Inc. | Chitosan-glycerol-water gel |
| JPS624702A (ja) | 1985-06-28 | 1987-01-10 | Lion Corp | 水溶性アシル化キトサンの製造方法 |
| JPH0790005A (ja) * | 1993-09-24 | 1995-04-04 | Daiichi Seimo Kk | 水溶性キトサンの製造法 |
| JP3118423B2 (ja) * | 1996-08-30 | 2000-12-18 | ツヤック株式会社 | 水溶性の部分アセチル化キトサン液の製造方法 |
| CA2212300A1 (en) | 1997-08-04 | 1999-02-04 | Abdellatif Chenite | In vitro or in vivo gelfying chitosan and therapeutic uses thereof |
| FR2822842B1 (fr) * | 2001-03-30 | 2004-11-19 | Genevrier Lab | Procede de preparation d'un neo-tissu cartilagineux |
| NO20015986D0 (no) * | 2001-08-02 | 2001-12-06 | Einar J Mustaparta | Produktet chitosan, samt fremstillingsmetode og anvendelse av chitosan |
| FR2836044A1 (fr) * | 2002-02-15 | 2003-08-22 | Octaris | Composition pour la reparation et la cicatrisation cutanee comprenant exclusivement un vrai hydrogel physique de chitosane |
| WO2005097871A1 (en) | 2004-03-22 | 2005-10-20 | Universite De Geneve | Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same |
| JP2007090005A (ja) | 2005-09-27 | 2007-04-12 | Oputisu Engineering Company:Kk | 腹筋等鍛練器具 |
| JP2010072502A (ja) | 2008-09-22 | 2010-04-02 | Hitachi Displays Ltd | 液晶表示装置 |
-
2004
- 2004-03-22 WO PCT/EP2004/002988 patent/WO2005097871A1/en not_active Ceased
- 2004-03-22 JP JP2007504258A patent/JP5083967B2/ja not_active Expired - Fee Related
- 2004-03-22 EP EP04722250A patent/EP1730216A1/en not_active Withdrawn
- 2004-03-22 CA CA2560432A patent/CA2560432C/en not_active Expired - Fee Related
- 2004-03-22 US US10/593,678 patent/US8835514B2/en not_active Expired - Fee Related
-
2009
- 2009-12-29 US US12/654,700 patent/US8507563B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8507563B2 (en) | 2013-08-13 |
| JP2007529559A (ja) | 2007-10-25 |
| US8835514B2 (en) | 2014-09-16 |
| US20070141142A1 (en) | 2007-06-21 |
| CA2560432C (en) | 2012-10-09 |
| EP1730216A1 (en) | 2006-12-13 |
| US20100113618A1 (en) | 2010-05-06 |
| CA2560432A1 (en) | 2005-10-20 |
| WO2005097871A1 (en) | 2005-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8507563B2 (en) | Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same | |
| Lotfy et al. | Optimizing the chitosan-cellulose based drug delivery system for controlling the ciprofloxacin release versus organic/inorganic crosslinker, characterization and kinetic study | |
| Pourjavadi et al. | Injectable chitosan/κ-carrageenan hydrogel designed with au nanoparticles: A conductive scaffold for tissue engineering demands | |
| Thomas et al. | Starch modified alginate nanoparticles for drug delivery application | |
| Mourya et al. | Carboxymethyl chitosan and its applications | |
| Jayakumar et al. | Novel carboxymethyl derivatives of chitin and chitosan materials and their biomedical applications | |
| Pal et al. | Interpenetrating polymer network hydrogels of chitosan: applications in controlling drug release | |
| US11672756B2 (en) | Temperature sensitive hydrogel composition including nucleic acid and chitosan | |
| EP1753787B1 (en) | Method of covalently linking hyaluronan and chitosan | |
| Li et al. | A covalently crosslinked polysaccharide hydrogel for potential applications in drug delivery and tissue engineering | |
| EP2199308B1 (en) | Swellable crosslinked hyaluronic acid powder and method for producing the same | |
| Kim et al. | Visible light induced dextran-methacrylate hydrogel formation using (−)-riboflavin vitamin B2 as a photoinitiator and L-arginine as a co-initiator | |
| Alotaibi et al. | Development of poly (vinyl alcohol)–Chitosan composite nanofibers for dual drug therapy of wounds | |
| JP5521250B2 (ja) | グリコールキトサン誘導体、その製造方法、及びこれを含む薬物伝達体 | |
| JP2003055401A (ja) | 多官能性架橋剤によって架橋したグリコサミノグリカン−ポリカチオン複合体とその製造法 | |
| Li et al. | In vitro and in vivo evaluation of 3D biodegradable thermo/pH sensitive sol-gel reversible hydroxybutyl chitosan hydrogel | |
| CN108014376A (zh) | 一种甜菜碱修饰壳聚糖的多糖水凝胶及其制备方法 | |
| JP4094059B2 (ja) | 低い多分散指数を有するヒアルロン酸分画の調整方法 | |
| JP2007529559A5 (enExample) | ||
| Tran et al. | Chitosan hydrogel containing silk fibroin nanofibrils for controllable properties and its application to drug delivery system | |
| Bi et al. | Temperature sensitive self-assembling hydroxybutyl chitosan nanoparticles with cationic enhancement effect for multi-functional applications | |
| JP5933178B2 (ja) | キトサンカルボキシアルキルアミドのヒドロゲル、その調製方法、並びに、無水生成物、皮膚科組成物および美容用組成物 | |
| Kumar et al. | Injectable mesquite gum and carboxymethyl chitosan hydrogel using schiff base crosslinks: a versatile platform for drug delivery in wound care | |
| Volod’ko et al. | Carrageenan films as promising mucoadhesive ocular drug delivery systems | |
| CN119632913A (zh) | 一种用于眼部药物缓释的可注射水凝胶及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20090714 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20090714 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100819 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20101118 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110317 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120202 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120531 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20120621 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120806 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120831 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150914 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |